SECOND SIGHT MED PRODS INC - COM NEW (EYES)

CUSIP: 81362J209

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM NEW
Total 13F shares
45,182
Share change
+43,878
Total reported value
$33,000
Price per share
$0.74
Number of holders
3
Value change
+$32,000
Number of buys
2

Quarterly Holders Quick Answers

What is CUSIP 81362J209?
CUSIP 81362J209 identifies EYES - SECOND SIGHT MED PRODS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM NEW (EYES) as of Q4 2019

As of 31 Dec 2019, SECOND SIGHT MED PRODS INC - COM NEW (EYES) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,182 shares. The largest 3 holders included B. Riley Wealth Management, Inc., Edge Wealth Management LLC, and tru Independence LLC. This page lists 3 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.